nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abuse Potential of Biased Mu Opioid Receptor Agonists
|
Negus, S. Stevens |
|
2018 |
39 |
11 |
p. 916-919 |
artikel |
2 |
A Tribute to Elliot S. Vesell (1933–2018)
|
Nebert, Daniel W. |
|
2018 |
39 |
11 |
p. 905-907 |
artikel |
3 |
‘Crystal’ Clear? Lysophospholipid Receptor Structure Insights and Controversies
|
Blaho, Victoria A. |
|
2018 |
39 |
11 |
p. 953-966 |
artikel |
4 |
Editorial Board and Contents
|
|
|
2018 |
39 |
11 |
p. i-ii |
artikel |
5 |
Immunopharmacotherapies for Treating Opioid Use Disorder
|
Banks, Matthew L. |
|
2018 |
39 |
11 |
p. 908-911 |
artikel |
6 |
Kill ‘Em All: Efgartigimod Immunotherapy for Autoimmune Diseases
|
Bayry, Jagadeesh |
|
2018 |
39 |
11 |
p. 919-922 |
artikel |
7 |
MicroRNAs: Novel Molecular Targets and Response Modulators of Statin Therapy
|
Mohajeri, Mohammad |
|
2018 |
39 |
11 |
p. 967-981 |
artikel |
8 |
Natural Products as a Source for Antifibrosis Therapy
|
Chen, Dan-Qian |
|
2018 |
39 |
11 |
p. 937-952 |
artikel |
9 |
Precision Medicine through Antisense Oligonucleotide-Mediated Exon Skipping
|
Li, Dunhui |
|
2018 |
39 |
11 |
p. 982-994 |
artikel |
10 |
Purinergic Signaling: A New Pharmacological Target Against Viruses?
|
Ferrari, Davide |
|
2018 |
39 |
11 |
p. 926-936 |
artikel |
11 |
Refining Early Antitumoral Drug Development
|
Ocaña, Alberto |
|
2018 |
39 |
11 |
p. 922-925 |
artikel |
12 |
Science-Based Actions Can Help Address the Opioid Crisis
|
Epstein, David H. |
|
2018 |
39 |
11 |
p. 911-916 |
artikel |